Who is sponsoring NCT01050166?

NCT01050166 is sponsored by Frantisek Saudek.

What drugs are being tested in NCT01050166?

Interventions in NCT01050166: Transplantation of labeled islets.

What condition does NCT01050166 study?

NCT01050166 studies Type 1 Diabetes Mellitus.

Is NCT01050166 still recruiting?

NCT01050166 is currently completed. Last updated 26 April 2021.

Last reviewed 2021-04-26 · How we verify

NCT01050166

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MRI Imaging of Labeled Human Islets Transplanted Into the Liver

Completed Last updated 26 April 2021

What this trial tests

trial testing Transplantation of labeled islets in Type 1 Diabetes Mellitus in 8 participants. Completed in 31 December 2012.

Timeline

15 August 2008

Primary endpoint
15 December 2012

31 December 2012

Quick facts

Lead sponsor	Frantisek Saudek
Status	Completed
Study type	OBSERVATIONAL
Enrollment	8
Start date	15 August 2008
Primary completion	15 December 2012
Estimated completion	31 December 2012
Sites	1 location across Czechia

Drugs / interventions tested

Transplantation of labeled islets

Conditions studied

Type 1 Diabetes Mellitus — all drugs for Type 1 Diabetes Mellitus →

Sponsor

Frantisek Saudek

Who can join

Adults 18 to 65, any sex, with Type 1 Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to determine whether human islets labeled by iron contrast agents could be imaged using magnetic resonance after transplantation into the liver of Type 1 diabetic recipients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Regenerative medicine of pancreatic islets.
Arutyunyan IV, Fatkhudinov TK, Makarov AV, Elchaninov AV, et al · · 2020 · cited 14× · PMID 32587441 · DOI 10.3748/wjg.v26.i22.2948

Verify or expand the search:

Other recruiting trials for Type 1 Diabetes Mellitus

Currently open trials in the same condition.

NCT07142252 — Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus · Phase 2 · recruiting
NCT07296276 — Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM · NA · recruiting
NCT07409701 — Gamification Intervertion in Children With Type 1 Diabetes · NA · recruiting
NCT07356089 — Twiist Postmarket Surveillance Study for Type 1 Diabetes · recruiting
NCT07434154 — Evaluation of Oxidative Stress: Comparison Between Type 1 Diabetes Mellitus and Latent Autoimmune Diabetes in Adults · recruiting

Other Frantisek Saudek trials

Trials by the same sponsor.

NCT04884633 — Novel Method of Pancreatic Islet Transplantation Into the Omentum · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01050166 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Frantisek Saudek
Last refreshed: 26 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01050166.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing